Package 68788-8537-1

{"route": ["ORAL"], "spl_id": "deaaeff9-8449-4873-8cc7-bf52f8044270", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["24ede961-8849-4f44-b007-8d120624a578"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-8537-1)", "package_ndc": "68788-8537-1", "marketing_start_date": "20231019"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-8537-3)", "package_ndc": "68788-8537-3", "marketing_start_date": "20231019"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-8537-6)", "package_ndc": "68788-8537-6", "marketing_start_date": "20231019"}, {"sample": false, "description": "120 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-8537-8)", "package_ndc": "68788-8537-8", "marketing_start_date": "20231019"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (68788-8537-9)", "package_ndc": "68788-8537-9", "marketing_start_date": "20231019"}], "brand_name": "Bupropion Hydrochloride (XL)", "product_id": "68788-8537_deaaeff9-8449-4873-8cc7-bf52f8044270", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "68788-8537", "generic_name": "bupropion hydrochloride", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "(XL)", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA206556", "marketing_category": "ANDA", "marketing_start_date": "20231019", "listing_expiration_date": "20261231"}